EORTC protocol 20963

Marrow ablative chemo-radiotherapy and autologous stem cell transplantation followed by interferon - alpha maintenance treatment versus interferon-alpha maintenance alone after a chemotherapy induced remission in patients with stages III or IV follicular HNL. A prospective, randomised phase III clinical trial.
Trial StatusAll trial activities ended
DatesDate of activation: 28-Mar-97
Date Step1 close: 15-Nov-99
Date Step2 close: 15-Nov-99
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size469
Number of steps2
Drug
Study StaffAnton Hagenbeek (Study Coordinator) - Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam
R. Marcus (Study Coordinator) - Kings College School Of Medecine, London
Bart Meulemans (Data Manager) - EORTC Headquarters, Brussels
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
British National Lymphoma Group
Hemato-Oncologie Volwassenen Nederland
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00003152
EudraCT
Back to Protocol section